Archive for 2005
Genentech’s Lessons For Big Pharma
How does Genentech do it? The biotech company focuses on science — not marketing, acquisitions, or patents
Brand Drug Prices Outpace Inflation
U.S. prices for brand-name drugs on average rose at 2.5 times the rate of inflation last year, while generic drug prices remained flat, according to a study released on Tuesday by the nation’s largest lobby for the elderly.
Clones’ beef, milk same as regular
There is no difference between meat and milk from cloned livestock and those foods obtained from conventionally bred cattle, according to a study released today.
FDA guidelines to help personalized drug development
As part of an agency-wide initiative to speed development of new medical products through the science of pharmacogenomics, the FDA has issued a final guidance regarding pharmacogenomic data submissions.
India Proposes End to Patent Drug Copying
India’s government proposed on Friday to change the country’s patent laws to make it illegal to copy patented drugs, a practice that has made cheaper medicines available in India and abroad.
Nearly 50 new biotech medicines in pipeline
There could be as many as 50 new biotechnology medicines approved for commercial use in the coming months, thanks to advances in biotechnology research and development, according to a study released March 7.
